[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO986086D0 - FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11 - Google Patents

FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11

Info

Publication number
NO986086D0
NO986086D0 NO986086A NO986086A NO986086D0 NO 986086 D0 NO986086 D0 NO 986086D0 NO 986086 A NO986086 A NO 986086A NO 986086 A NO986086 A NO 986086A NO 986086 D0 NO986086 D0 NO 986086D0
Authority
NO
Norway
Prior art keywords
pregnan
dihalo
alpha
esters
preparation
Prior art date
Application number
NO986086A
Other languages
English (en)
Other versions
NO986086L (no
NO312367B1 (no
Inventor
Daw-Iong Albert Kwok
David J S Tsai
Chou-Hong Tann
Xiaoyong Fu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO986086D0 publication Critical patent/NO986086D0/no
Publication of NO986086L publication Critical patent/NO986086L/no
Publication of NO312367B1 publication Critical patent/NO312367B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19986086A 1996-06-28 1998-12-23 Fremgangsmåte for fremstilling av 17-estere av 9<alfa>,21- dihalopregnan-11<beta>,17<alfa>-diol-20-oner NO312367B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67286196A 1996-06-28 1996-06-28
PCT/US1997/010121 WO1998000437A1 (en) 1996-06-28 1997-06-25 PROCESS FOR THE PREPARATION OF 17-ESTERS OF 9α,21-DIHALO-PREGNANE-11β,17αDIOL-20-ONES

Publications (3)

Publication Number Publication Date
NO986086D0 true NO986086D0 (no) 1998-12-23
NO986086L NO986086L (no) 1999-02-16
NO312367B1 NO312367B1 (no) 2002-04-29

Family

ID=24700321

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19986086A NO312367B1 (no) 1996-06-28 1998-12-23 Fremgangsmåte for fremstilling av 17-estere av 9<alfa>,21- dihalopregnan-11<beta>,17<alfa>-diol-20-oner

Country Status (21)

Country Link
EP (1) EP0923599B1 (no)
JP (3) JP4269110B2 (no)
KR (1) KR100441187B1 (no)
CN (1) CN1158296C (no)
AR (1) AR007485A1 (no)
AT (1) ATE212035T1 (no)
AU (1) AU725606B2 (no)
BR (1) BR9710081A (no)
CA (1) CA2258681C (no)
CZ (1) CZ293944B6 (no)
DE (1) DE69709655T2 (no)
DK (1) DK0923599T3 (no)
ES (1) ES2166549T3 (no)
HK (1) HK1017899A1 (no)
IL (1) IL127782A (no)
NO (1) NO312367B1 (no)
NZ (1) NZ333410A (no)
PL (1) PL185637B1 (no)
PT (1) PT923599E (no)
SK (1) SK283666B6 (no)
WO (1) WO1998000437A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT102343B (pt) * 1999-08-02 2003-11-28 Hovione Farmaciencia Sa Processo para a preparacao de furoato mometasona
PT102405A (pt) * 2000-01-20 2001-07-31 Hovione Farmaciencia Sa Processo para a preparacao de mometasona
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266519B (zh) * 2016-04-08 2021-06-29 天津金耀集团有限公司 一种9β，11β-环氧-17α-羟基-16α-甲基-21-氯代-1，4孕甾二烯-3，20-二酮新晶型及其制备方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN106279340B (zh) * 2016-08-10 2018-07-20 山东京卫制药有限公司 一种合成糠酸莫米松或其一水合物的方法
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物
CN109206468B (zh) * 2017-06-30 2023-06-27 天津药业研究院股份有限公司 一种糠酸莫米松的制备方法
CN109206466B (zh) * 2017-06-30 2022-08-09 天津药业研究院股份有限公司 一种甾体21位羟基氯代或溴代方法
CN109517019B (zh) * 2017-09-18 2021-12-07 华东师范大学 一种3β-乙酰氧基雄甾-5-烯-17-酮加成反应副产物的再利用方法
CN112110975A (zh) * 2019-06-21 2020-12-22 河南利华制药有限公司 一种一勺烩工艺合成糠酸莫米松的方法
CN112110972B (zh) * 2019-06-21 2022-03-18 河南利华制药有限公司 一种氯倍他索丙酸酯的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2713587A (en) * 1952-03-08 1955-07-19 Searle & Co 11, 17-dihydroxy-4-pregnene-3, 20-dione
US2793207A (en) * 1954-11-01 1957-05-21 Searle & Co Steroidal thiazole derivatives
US3440252A (en) * 1965-06-23 1969-04-22 Glaxo Lab Ltd Preparation of 21-deoxy steroids
US3502700A (en) * 1967-01-19 1970-03-24 Squibb & Sons Inc 17-esters of 9alpha,21-dihalo-11beta,17alpha-dihydroxyprogesterones
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2012149076A (ja) 2012-08-09
JP4269110B2 (ja) 2009-05-27
KR100441187B1 (ko) 2004-11-03
KR20000022547A (ko) 2000-04-25
NZ333410A (en) 2000-06-23
IL127782A0 (en) 1999-10-28
AU725606B2 (en) 2000-10-12
DE69709655D1 (de) 2002-02-21
DK0923599T3 (da) 2002-04-22
JP2009035552A (ja) 2009-02-19
JP5061061B2 (ja) 2012-10-31
DE69709655T2 (de) 2002-09-12
EP0923599B1 (en) 2002-01-16
CZ293944B6 (cs) 2004-08-18
NO986086L (no) 1999-02-16
SK177898A3 (en) 2000-04-10
CN1228782A (zh) 1999-09-15
AU3483597A (en) 1998-01-21
CA2258681C (en) 2006-11-14
PT923599E (pt) 2002-06-28
NO312367B1 (no) 2002-04-29
CN1158296C (zh) 2004-07-21
WO1998000437A1 (en) 1998-01-08
PL185637B1 (pl) 2003-06-30
CA2258681A1 (en) 1998-01-08
BR9710081A (pt) 1999-08-10
HK1017899A1 (en) 1999-12-03
PL330843A1 (en) 1999-06-07
EP0923599A1 (en) 1999-06-23
CZ417798A3 (cs) 1999-05-12
SK283666B6 (sk) 2003-11-04
ATE212035T1 (de) 2002-02-15
AR007485A1 (es) 1999-10-27
ES2166549T3 (es) 2002-04-16
JP2000514058A (ja) 2000-10-24
IL127782A (en) 2004-06-20

Similar Documents

Publication Publication Date Title
NO20021714D0 (no) 2-fenyl-substituerte imidazotriazinoner, fremgangsmåte for fremstilling derav samt anvendelse av forbindelsene
NO970153L (no) Fremgangsmåte for syntese av substituerte sulfoksider
NO20011936D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO986086D0 (no) FremgangsmÕte for fremstilling av 17-estere av 9&lt;alfa&gt;,21-dihalo-pregnan-11
NO983068D0 (no) FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
NO20012470L (no) Fremgangsmåte for fremstilling av 1-substituerte 5- eller 3- hydroksypyrazoler
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
ZA988397B (en) Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20005743L (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO961577L (no) Fremgangsmåte for fremstilling av tre-polymer-kompositter
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
FI970039A (fi) Menetelmä 5-aryyli-2,4-dialkyyli-3H-1,2,3-triatsoli-3-tionien valmistamiseksi
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
NO995939D0 (no) Fremgangsmåte for fremstilling av chirale 3,4-dehydroproliner
FI932887A (fi) Parannettu menetelmä 4-nitro-3-trifluorometyylianiliinin valmistamiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees